[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fXwfUqoznBPi28U1m7srLO7ihu8aymPZZbg7blQXJCbM":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":33,"phaseBuckets":64,"rows":71},"Meir Medical Center",[4],395,false,27,13,80818,6,314,[14,17,19,21,24,26,28,30],{"name":15,"count":16},"Infertility",9,{"name":18,"count":16},"Obesity",{"name":20,"count":11},"Pregnancy",{"name":22,"count":23},"Childhood Obesity",4,{"name":25,"count":23},"Food Allergy",{"name":27,"count":23},"Vitamin D Deficiency",{"name":29,"count":23},"Healthy",{"name":31,"count":32},"Crohn's Disease",3,[34,39,44,49,54,59],{"nctId":35,"briefTitle":36,"date":37,"intervention":38},"NCT04760301","Local Tranexamic Acid During Vaginal Hysteractomy to Reduce Blood Loss","2025-07","local tranexamic acid",{"nctId":40,"briefTitle":41,"date":42,"intervention":43},"NCT05232045","Automated System for Monitoring Urine Output in Intensive Care Patients","2026-01","Automated urinary output collection system group",{"nctId":45,"briefTitle":46,"date":47,"intervention":48},"NCT06154382","Eltroxin Administration to Patients With Extremely Low T4 Values in the Intensive Care Unit","2026-02-01","Eltroxin administration",{"nctId":50,"briefTitle":51,"date":52,"intervention":53},"NCT06206759","Vitamin C Administration and Triglycerides Level in Critical Care Patients","2027-02-01","administration of vitamin C",{"nctId":55,"briefTitle":56,"date":57,"intervention":58},"NCT06591247","Membrane Stripping for Cervical Ripening","2027-12-31","PGE2",{"nctId":60,"briefTitle":61,"date":62,"intervention":63},"NCT05784350","Preoperative Point of Care Ultrasound Guided Fluid Optimization and Intravenous Ondansetron to Prevent General Anesthesia-Induced Hypotension","2028-05-01","fluid boluses guided by IVC diameter via US\u002Fadministration of pre-operative IV Odansetrone",[65,66,67,68,69,70],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[72,96,119,140,166,187,208,233,260,286,304,330,348,373,399,423,447,471,496,522,547,571,596,620,673,701,731,756,774,792,816,834,860,884,905,923,948,971,994,1017,1035,1060,1078,1103,1128,1151,1169,1194,1217,1268,1304,1329,1353,1376,1402,1428,1446,1471,1494,1519,1537,1561,1586,1612,1635,1657,1683,1709,1727,1745,1763,1787,1805,1829,1854,1872,1896,1914,1940,1962,1986,2011,2034,2057,2083,2109,2133,2158,2176,2198,2222],{"intervention":63,"totalTrials":73,"cells":74},1,{"EARLY_PHASE1":75,"PHASE1":78,"PHASE2":80,"PHASE3":82,"PHASE4":84,"NA":86},{"trials":76,"activeCount":77},[],0,{"trials":79,"activeCount":77},[],{"trials":81,"activeCount":77},[],{"trials":83,"activeCount":77},[],{"trials":85,"activeCount":77},[],{"trials":87,"activeCount":73,"soonestReadout":62},[88],{"nctId":60,"briefTitle":61,"status":89,"phases":90,"primaryCompletion":62,"completion":62,"start":91,"enrollment":92,"conditions":93,"interventions":95},"NOT_YET_RECRUITING",[70],"2025-08-01",150,[94],"Intra-operative Hypotension",[63],{"intervention":38,"totalTrials":73,"cells":97},{"EARLY_PHASE1":98,"PHASE1":100,"PHASE2":102,"PHASE3":104,"PHASE4":106,"NA":108},{"trials":99,"activeCount":77},[],{"trials":101,"activeCount":77},[],{"trials":103,"activeCount":77},[],{"trials":105,"activeCount":77},[],{"trials":107,"activeCount":77},[],{"trials":109,"activeCount":73,"soonestReadout":37},[110],{"nctId":35,"briefTitle":36,"status":111,"phases":112,"primaryCompletion":37,"completion":113,"start":114,"enrollment":115,"conditions":116,"interventions":118},"RECRUITING",[70],"2026-06","2021-02-16",60,[117],"Blood Loss",[38],{"intervention":48,"totalTrials":73,"cells":120},{"EARLY_PHASE1":121,"PHASE1":123,"PHASE2":125,"PHASE3":127,"PHASE4":129,"NA":131},{"trials":122,"activeCount":77},[],{"trials":124,"activeCount":77},[],{"trials":126,"activeCount":77},[],{"trials":128,"activeCount":77},[],{"trials":130,"activeCount":77},[],{"trials":132,"activeCount":73,"soonestReadout":47},[133],{"nctId":45,"briefTitle":46,"status":111,"phases":134,"primaryCompletion":47,"completion":47,"start":135,"enrollment":136,"conditions":137,"interventions":139},[],"2024-06-01",350,[138],"Thyroid; Functional Disturbance",[48],{"intervention":58,"totalTrials":73,"cells":141},{"EARLY_PHASE1":142,"PHASE1":144,"PHASE2":146,"PHASE3":148,"PHASE4":150,"NA":152},{"trials":143,"activeCount":77},[],{"trials":145,"activeCount":77},[],{"trials":147,"activeCount":77},[],{"trials":149,"activeCount":77},[],{"trials":151,"activeCount":77},[],{"trials":153,"activeCount":73,"soonestReadout":57},[154],{"nctId":55,"briefTitle":56,"status":111,"phases":155,"primaryCompletion":57,"completion":57,"start":156,"enrollment":157,"conditions":158,"interventions":165},[70],"2024-08-07",400,[159,160,161,162,163,164],"Labor, Induced","Cervical Ripening","Balloon Induction","Membrane Stripping","Pregnancy Related","Induction of Birth",[58],{"intervention":53,"totalTrials":73,"cells":167},{"EARLY_PHASE1":168,"PHASE1":170,"PHASE2":172,"PHASE3":174,"PHASE4":176,"NA":178},{"trials":169,"activeCount":77},[],{"trials":171,"activeCount":77},[],{"trials":173,"activeCount":77},[],{"trials":175,"activeCount":77},[],{"trials":177,"activeCount":77},[],{"trials":179,"activeCount":73,"soonestReadout":52},[180],{"nctId":50,"briefTitle":51,"status":111,"phases":181,"primaryCompletion":52,"completion":52,"start":182,"enrollment":183,"conditions":184,"interventions":186},[],"2024-05-01",2000,[185],"Hypertriglyceridemia",[53],{"intervention":43,"totalTrials":73,"cells":188},{"EARLY_PHASE1":189,"PHASE1":191,"PHASE2":193,"PHASE3":195,"PHASE4":197,"NA":199},{"trials":190,"activeCount":77},[],{"trials":192,"activeCount":77},[],{"trials":194,"activeCount":77},[],{"trials":196,"activeCount":77},[],{"trials":198,"activeCount":77},[],{"trials":200,"activeCount":73,"soonestReadout":42},[201],{"nctId":40,"briefTitle":41,"status":89,"phases":202,"primaryCompletion":42,"completion":113,"start":203,"enrollment":204,"conditions":205,"interventions":207},[],"2025-12",1800,[206],"Acute Kidney Injury in the ICU",[43],{"intervention":209,"totalTrials":73,"cells":210},"estradiol valerate",{"EARLY_PHASE1":211,"PHASE1":213,"PHASE2":215,"PHASE3":217,"PHASE4":219,"NA":231},{"trials":212,"activeCount":77},[],{"trials":214,"activeCount":77},[],{"trials":216,"activeCount":77},[],{"trials":218,"activeCount":77},[],{"trials":220,"activeCount":77},[221],{"nctId":222,"briefTitle":223,"status":224,"phases":225,"primaryCompletion":226,"completion":226,"start":227,"enrollment":228,"conditions":229,"interventions":230},"NCT01419353","Programming by Estrogen Treatment in Gonadotropin Releasing Hormone Antagonist Protocol","COMPLETED",[69],"2013-06","2011-08",63,[15],[209],{"trials":232,"activeCount":77},[],{"intervention":234,"totalTrials":73,"cells":235},"Aliskiren",{"EARLY_PHASE1":236,"PHASE1":238,"PHASE2":240,"PHASE3":242,"PHASE4":244,"NA":258},{"trials":237,"activeCount":77},[],{"trials":239,"activeCount":77},[],{"trials":241,"activeCount":77},[],{"trials":243,"activeCount":77},[],{"trials":245,"activeCount":77},[246],{"nctId":247,"briefTitle":248,"status":249,"phases":250,"primaryCompletion":251,"completion":252,"start":253,"enrollment":254,"conditions":255,"interventions":257},"NCT01060865","Evaluation of Aliskiren Efficacy by Different Methods of Blood Pressure Measurements","TERMINATED",[69],"2011-10","2011-12","2010-03",50,[256],"Blood Pressure, High",[234],{"trials":259,"activeCount":77},[],{"intervention":261,"totalTrials":73,"cells":262},"Spinal Block",{"EARLY_PHASE1":263,"PHASE1":265,"PHASE2":267,"PHASE3":269,"PHASE4":271,"NA":284},{"trials":264,"activeCount":77},[],{"trials":266,"activeCount":77},[],{"trials":268,"activeCount":77},[],{"trials":270,"activeCount":77},[],{"trials":272,"activeCount":77},[273],{"nctId":274,"briefTitle":275,"status":276,"phases":277,"primaryCompletion":278,"completion":278,"start":279,"enrollment":115,"conditions":280,"interventions":282},"NCT03176758","Postoperative Pain in Total Knee Arthroplasty: a Comparison Between General and Spinal Anesthesia","UNKNOWN",[69],"2018-06-01","2017-06-01",[281],"Total Knee Replacement Surgery",[261,283],"General anesthetic",{"trials":285,"activeCount":77},[],{"intervention":283,"totalTrials":73,"cells":287},{"EARLY_PHASE1":288,"PHASE1":290,"PHASE2":292,"PHASE3":294,"PHASE4":296,"NA":302},{"trials":289,"activeCount":77},[],{"trials":291,"activeCount":77},[],{"trials":293,"activeCount":77},[],{"trials":295,"activeCount":77},[],{"trials":297,"activeCount":77},[298],{"nctId":274,"briefTitle":275,"status":276,"phases":299,"primaryCompletion":278,"completion":278,"start":279,"enrollment":115,"conditions":300,"interventions":301},[69],[281],[261,283],{"trials":303,"activeCount":77},[],{"intervention":305,"totalTrials":73,"cells":306},"Insulin treatment during Ramadan",{"EARLY_PHASE1":307,"PHASE1":309,"PHASE2":311,"PHASE3":313,"PHASE4":315,"NA":328},{"trials":308,"activeCount":77},[],{"trials":310,"activeCount":77},[],{"trials":312,"activeCount":77},[],{"trials":314,"activeCount":77},[],{"trials":316,"activeCount":77},[317],{"nctId":318,"briefTitle":319,"status":224,"phases":320,"primaryCompletion":321,"completion":251,"start":321,"enrollment":322,"conditions":323,"interventions":326},"NCT01354925","Management of Type-2 Diabetic Patients Treated With Insulin During the Ramadan",[69],"2011-09",245,[324,325],"Diabetes Type 2","Treatment During Ramadan",[305,327],"Standard of care",{"trials":329,"activeCount":77},[],{"intervention":327,"totalTrials":73,"cells":331},{"EARLY_PHASE1":332,"PHASE1":334,"PHASE2":336,"PHASE3":338,"PHASE4":340,"NA":346},{"trials":333,"activeCount":77},[],{"trials":335,"activeCount":77},[],{"trials":337,"activeCount":77},[],{"trials":339,"activeCount":77},[],{"trials":341,"activeCount":77},[342],{"nctId":318,"briefTitle":319,"status":224,"phases":343,"primaryCompletion":321,"completion":251,"start":321,"enrollment":322,"conditions":344,"interventions":345},[69],[324,325],[305,327],{"trials":347,"activeCount":77},[],{"intervention":349,"totalTrials":73,"cells":350},"Mitomycin C 0.02%",{"EARLY_PHASE1":351,"PHASE1":353,"PHASE2":355,"PHASE3":357,"PHASE4":359,"NA":371},{"trials":352,"activeCount":77},[],{"trials":354,"activeCount":77},[],{"trials":356,"activeCount":77},[],{"trials":358,"activeCount":77},[],{"trials":360,"activeCount":77},[361],{"nctId":362,"briefTitle":363,"status":276,"phases":364,"primaryCompletion":365,"completion":365,"start":366,"enrollment":367,"conditions":368,"interventions":370},"NCT02641132","Pterygium Head Body MMC1: Two Different Surgical Procedures and Their Effect on Endothelial Cell Count.",[69],"2016-12","2015-09",62,[369],"Pterygium",[349],{"trials":372,"activeCount":77},[],{"intervention":374,"totalTrials":73,"cells":375},"etoricoxib",{"EARLY_PHASE1":376,"PHASE1":378,"PHASE2":380,"PHASE3":382,"PHASE4":384,"NA":397},{"trials":377,"activeCount":77},[],{"trials":379,"activeCount":77},[],{"trials":381,"activeCount":77},[],{"trials":383,"activeCount":77},[],{"trials":385,"activeCount":77},[386],{"nctId":387,"briefTitle":388,"status":276,"phases":389,"primaryCompletion":390,"completion":391,"start":392,"enrollment":393,"conditions":394,"interventions":396},"NCT00755521","Study Assessing the Efficacy of Etoricoxib in Female Patients With Fibromyalgia",[69],"2010-10","2012-12","2008-09",80,[395],"Fibromyalgia",[374],{"trials":398,"activeCount":77},[],{"intervention":400,"totalTrials":73,"cells":401},"Doxorubicin",{"EARLY_PHASE1":402,"PHASE1":404,"PHASE2":406,"PHASE3":408,"PHASE4":410,"NA":421},{"trials":403,"activeCount":77},[],{"trials":405,"activeCount":77},[],{"trials":407,"activeCount":77},[],{"trials":409,"activeCount":77},[],{"trials":411,"activeCount":77},[412],{"nctId":413,"briefTitle":414,"status":224,"phases":415,"primaryCompletion":252,"completion":391,"start":416,"enrollment":417,"conditions":418,"interventions":420},"NCT00969462","Doxorubicin Pharmacokinetics and Response in Non Hodgkin's Lymphoma",[69],"2009-09",18,[419],"Non-Hodgkin's Lymphoma",[400],{"trials":422,"activeCount":77},[],{"intervention":424,"totalTrials":73,"cells":425},"Dexamethasone Phosphate",{"EARLY_PHASE1":426,"PHASE1":428,"PHASE2":430,"PHASE3":432,"PHASE4":434,"NA":445},{"trials":427,"activeCount":77},[],{"trials":429,"activeCount":77},[],{"trials":431,"activeCount":77},[],{"trials":433,"activeCount":77},[],{"trials":435,"activeCount":77},[436],{"nctId":437,"briefTitle":438,"status":224,"phases":439,"primaryCompletion":226,"completion":226,"start":440,"enrollment":441,"conditions":442,"interventions":444},"NCT01372904","Prevention of Cisplatin-Induced Hearing Loss by Intratympanic Dexamethasone Treatment",[69],"2011-06",30,[443],"Cisplatin Ototoxicity",[424],{"trials":446,"activeCount":77},[],{"intervention":448,"totalTrials":73,"cells":449},"venom immunotherapy",{"EARLY_PHASE1":450,"PHASE1":452,"PHASE2":454,"PHASE3":456,"PHASE4":458,"NA":469},{"trials":451,"activeCount":77},[],{"trials":453,"activeCount":77},[],{"trials":455,"activeCount":77},[],{"trials":457,"activeCount":77},[],{"trials":459,"activeCount":77},[460],{"nctId":461,"briefTitle":462,"status":224,"phases":463,"completion":464,"start":465,"enrollment":115,"conditions":466,"interventions":468},"NCT00684476","Maintenance Bee-Venom Immunotherapy Administered at 6-Month Intervals Does Not Protect Against re-Stings",[69],"2006-05","2004-06",[467],"Venom Allergy",[448],{"trials":470,"activeCount":77},[],{"intervention":472,"totalTrials":73,"cells":473},"Ropivacaine, Diclofenac, Water for",{"EARLY_PHASE1":474,"PHASE1":476,"PHASE2":478,"PHASE3":480,"PHASE4":482,"NA":494},{"trials":475,"activeCount":77},[],{"trials":477,"activeCount":77},[],{"trials":479,"activeCount":77},[],{"trials":481,"activeCount":77},[],{"trials":483,"activeCount":77},[484],{"nctId":485,"briefTitle":486,"status":224,"phases":487,"primaryCompletion":488,"completion":488,"start":489,"enrollment":490,"conditions":491,"interventions":493},"NCT00801528","Diclofenac vs. Ropivacaine for Cesarean Section",[69],"2008-12","2008-04",75,[492],"Cesarean Section",[472],{"trials":495,"activeCount":77},[],{"intervention":497,"totalTrials":73,"cells":498},"Methotrexate",{"EARLY_PHASE1":499,"PHASE1":501,"PHASE2":503,"PHASE3":505,"PHASE4":507,"NA":520},{"trials":500,"activeCount":77},[],{"trials":502,"activeCount":77},[],{"trials":504,"activeCount":77},[],{"trials":506,"activeCount":77},[],{"trials":508,"activeCount":77},[509],{"nctId":510,"briefTitle":511,"status":276,"phases":512,"primaryCompletion":513,"completion":514,"start":515,"enrollment":516,"conditions":517,"interventions":519},"NCT01860690","BHCG Level in Day 4,7, in Comparison to Day 10 as an Indicator for Treatment Success",[69],"2013-11","2014-02","2011-11",100,[518],"Ectopic Pregnancy",[497],{"trials":521,"activeCount":77},[],{"intervention":523,"totalTrials":73,"cells":524},"Lercanidipine\u002Fenalapril fixed combination",{"EARLY_PHASE1":525,"PHASE1":527,"PHASE2":529,"PHASE3":531,"PHASE4":533,"NA":545},{"trials":526,"activeCount":77},[],{"trials":528,"activeCount":77},[],{"trials":530,"activeCount":77},[],{"trials":532,"activeCount":77},[],{"trials":534,"activeCount":77},[535],{"nctId":536,"briefTitle":537,"status":249,"phases":538,"primaryCompletion":252,"completion":539,"start":540,"enrollment":541,"conditions":542,"interventions":544},"NCT01211314","Antihypertensive Efficacy of Fixed Combination Drug",[69],"2012-04","2011-01",10,[543],"Hypertension",[523],{"trials":546,"activeCount":77},[],{"intervention":548,"totalTrials":73,"cells":549},"Gabapentin, Etoricoxib, Sugar pill",{"EARLY_PHASE1":550,"PHASE1":552,"PHASE2":554,"PHASE3":556,"PHASE4":558,"NA":569},{"trials":551,"activeCount":77},[],{"trials":553,"activeCount":77},[],{"trials":555,"activeCount":77},[],{"trials":557,"activeCount":77},[],{"trials":559,"activeCount":77},[560],{"nctId":561,"briefTitle":562,"status":224,"phases":563,"primaryCompletion":564,"completion":564,"start":565,"enrollment":490,"conditions":566,"interventions":568},"NCT00799149","Etoricoxib Versus Gabapentin for Knee Arthroscopy",[69],"2007-05","2006-06",[567],"Knee Arthroscopy",[548],{"trials":570,"activeCount":77},[],{"intervention":572,"totalTrials":73,"cells":573},"Tramadol",{"EARLY_PHASE1":574,"PHASE1":576,"PHASE2":578,"PHASE3":580,"PHASE4":582,"NA":594},{"trials":575,"activeCount":77},[],{"trials":577,"activeCount":77},[],{"trials":579,"activeCount":77},[],{"trials":581,"activeCount":77},[],{"trials":583,"activeCount":77},[584],{"nctId":585,"briefTitle":586,"status":276,"phases":587,"primaryCompletion":588,"completion":589,"start":590,"enrollment":516,"conditions":591,"interventions":593},"NCT02706509","Pain Management Associated With the Insertion of Jaydess® in Nulliparous Women",[69],"2017-09","2018-12","2016-03",[592],"IUD Insertion Complication",[572],{"trials":595,"activeCount":77},[],{"intervention":597,"totalTrials":73,"cells":598},"Penicillin test and challenge",{"EARLY_PHASE1":599,"PHASE1":601,"PHASE2":603,"PHASE3":605,"PHASE4":607,"NA":618},{"trials":600,"activeCount":77},[],{"trials":602,"activeCount":77},[],{"trials":604,"activeCount":77},[],{"trials":606,"activeCount":77},[],{"trials":608,"activeCount":77},[609],{"nctId":610,"briefTitle":611,"status":249,"phases":612,"completion":613,"start":614,"conditions":615,"interventions":617},"NCT00363688","Treating Patients With a History of Non-Life Threatening Allergic Reaction to Penicillin With Penicillin",[69],"2004-05","1998-01",[616],"Penicillin Allergy",[597],{"trials":619,"activeCount":77},[],{"intervention":621,"totalTrials":23,"cells":622},"PRGF",{"EARLY_PHASE1":623,"PHASE1":625,"PHASE2":638,"PHASE3":640,"PHASE4":669,"NA":671},{"trials":624,"activeCount":77},[],{"trials":626,"activeCount":77},[627],{"nctId":628,"briefTitle":629,"status":630,"phases":631,"primaryCompletion":632,"completion":633,"start":634,"enrollment":77,"conditions":635,"interventions":637},"NCT01152658","Partial Tear of Supraspinatus (SSP) and Treatment With Plasma Rich in Growth Factors (PRGF)","WITHDRAWN",[66],"2012-05","2012-06","2010-04",[636],"Partial Supraspinatus Tear",[621],{"trials":639,"activeCount":77},[],{"trials":641,"activeCount":77},[642,652,661],{"nctId":643,"briefTitle":644,"status":224,"phases":645,"primaryCompletion":646,"completion":647,"start":648,"enrollment":254,"conditions":649,"interventions":651},"NCT00726245","Plasma Rich in Growth Factors (PRGF) Treatment for Muscle Tear",[67,68],"2009-02","2011-03","2008-01",[650],"Muscle Tear",[621],{"nctId":653,"briefTitle":654,"status":224,"phases":655,"primaryCompletion":646,"completion":656,"start":657,"enrollment":254,"conditions":658,"interventions":660},"NCT00731068","Platelet Rich Plasma (PRP) as a Treatment for ACHILLES Tendon Tears",[67,68],"2009-03","2007-02",[659],"Achilles Tendon Tear",[621],{"nctId":662,"briefTitle":663,"status":224,"phases":664,"primaryCompletion":646,"completion":656,"start":648,"enrollment":115,"conditions":665,"interventions":667},"NCT00728611","Preparation Rich in Growth Factors (PRGF) Treatment for Osteoarthritis of the Knee",[67,68],[666],"Osteoarthritis of the Knee",[621,668],"hyaluronic acid",{"trials":670,"activeCount":77},[],{"trials":672,"activeCount":77},[],{"intervention":668,"totalTrials":674,"cells":675},2,{"EARLY_PHASE1":676,"PHASE1":678,"PHASE2":680,"PHASE3":682,"PHASE4":697,"NA":699},{"trials":677,"activeCount":77},[],{"trials":679,"activeCount":77},[],{"trials":681,"activeCount":77},[],{"trials":683,"activeCount":77},[684,688],{"nctId":662,"briefTitle":663,"status":224,"phases":685,"primaryCompletion":646,"completion":656,"start":648,"enrollment":115,"conditions":686,"interventions":687},[67,68],[666],[621,668],{"nctId":689,"briefTitle":690,"status":276,"phases":691,"primaryCompletion":391,"completion":692,"start":321,"enrollment":516,"conditions":693,"interventions":694},"NCT01270412","Platelet Rich Plasma (PRP) as a Treatment for Knee Osteoarthritis PRP as a Treatment for Knee Osteoarthritis",[67,68],"2013-12",[666],[695,696],"Platelet Rich Plasma","Hyaluronic acid",{"trials":698,"activeCount":77},[],{"trials":700,"activeCount":77},[],{"intervention":702,"totalTrials":674,"cells":703},"Plasma Rich in Growth Factors",{"EARLY_PHASE1":704,"PHASE1":706,"PHASE2":708,"PHASE3":710,"PHASE4":727,"NA":729},{"trials":705,"activeCount":77},[],{"trials":707,"activeCount":77},[],{"trials":709,"activeCount":77},[],{"trials":711,"activeCount":77},[712,720],{"nctId":713,"briefTitle":714,"status":630,"phases":715,"primaryCompletion":646,"completion":656,"start":648,"enrollment":254,"conditions":716,"interventions":718},"NCT00743886","Influence of Plasma Rich in Growth Factors (PRGF) on Healing of Medial Collateral Ligament (MCL) Tear",[67,68],[717],"MCL Tear",[702,719],"saline",{"nctId":721,"briefTitle":722,"status":224,"phases":723,"primaryCompletion":646,"completion":656,"start":648,"enrollment":254,"conditions":724,"interventions":726},"NCT00743873","Platelet-rich Plasma (PRP) Treatment for Medial Retinaculum Tear Post Medial Patellar Dislocation",[67,68],[725],"Patella-Dislocation",[702],{"trials":728,"activeCount":77},[],{"trials":730,"activeCount":77},[],{"intervention":732,"totalTrials":73,"cells":733},"17 alfa hydroxyprogesterone caproate",{"EARLY_PHASE1":734,"PHASE1":736,"PHASE2":738,"PHASE3":740,"PHASE4":752,"NA":754},{"trials":735,"activeCount":77},[],{"trials":737,"activeCount":77},[],{"trials":739,"activeCount":77},[],{"trials":741,"activeCount":77},[742],{"nctId":743,"briefTitle":744,"status":276,"phases":745,"primaryCompletion":391,"completion":391,"start":746,"enrollment":747,"conditions":748,"interventions":749},"NCT00809939","17 Alfa Hydroxyprogesterone Caproate Versus Natural Progesterone for the Prevention of Preterm Labor",[68],"2010-12",800,[20],[732,750,732,751],"natural progesterone","vaginal progesterone",{"trials":753,"activeCount":77},[],{"trials":755,"activeCount":77},[],{"intervention":750,"totalTrials":73,"cells":757},{"EARLY_PHASE1":758,"PHASE1":760,"PHASE2":762,"PHASE3":764,"PHASE4":770,"NA":772},{"trials":759,"activeCount":77},[],{"trials":761,"activeCount":77},[],{"trials":763,"activeCount":77},[],{"trials":765,"activeCount":77},[766],{"nctId":743,"briefTitle":744,"status":276,"phases":767,"primaryCompletion":391,"completion":391,"start":746,"enrollment":747,"conditions":768,"interventions":769},[68],[20],[732,750,732,751],{"trials":771,"activeCount":77},[],{"trials":773,"activeCount":77},[],{"intervention":751,"totalTrials":73,"cells":775},{"EARLY_PHASE1":776,"PHASE1":778,"PHASE2":780,"PHASE3":782,"PHASE4":788,"NA":790},{"trials":777,"activeCount":77},[],{"trials":779,"activeCount":77},[],{"trials":781,"activeCount":77},[],{"trials":783,"activeCount":77},[784],{"nctId":743,"briefTitle":744,"status":276,"phases":785,"primaryCompletion":391,"completion":391,"start":746,"enrollment":747,"conditions":786,"interventions":787},[68],[20],[732,750,732,751],{"trials":789,"activeCount":77},[],{"trials":791,"activeCount":77},[],{"intervention":793,"totalTrials":73,"cells":794},"Metformin 1500 mg daily",{"EARLY_PHASE1":795,"PHASE1":797,"PHASE2":799,"PHASE3":801,"PHASE4":812,"NA":814},{"trials":796,"activeCount":77},[],{"trials":798,"activeCount":77},[],{"trials":800,"activeCount":77},[],{"trials":802,"activeCount":77},[803],{"nctId":804,"briefTitle":805,"status":276,"phases":806,"primaryCompletion":252,"completion":391,"start":807,"enrollment":808,"conditions":809,"interventions":810},"NCT00684528","A Double-Blind, Randomized, Active-Comparator (Metformin) Controlled, Clinical Trial to Study the Efficacy and Safety of the Strategy to Start Patients With Type 2 Diabetes Mellitus on Janumet™ Compared to Metformin",[68],"2008-06",1000,[324],[793,811],"Metformin + Janufer",{"trials":813,"activeCount":77},[],{"trials":815,"activeCount":77},[],{"intervention":811,"totalTrials":73,"cells":817},{"EARLY_PHASE1":818,"PHASE1":820,"PHASE2":822,"PHASE3":824,"PHASE4":830,"NA":832},{"trials":819,"activeCount":77},[],{"trials":821,"activeCount":77},[],{"trials":823,"activeCount":77},[],{"trials":825,"activeCount":77},[826],{"nctId":804,"briefTitle":805,"status":276,"phases":827,"primaryCompletion":252,"completion":391,"start":807,"enrollment":808,"conditions":828,"interventions":829},[68],[324],[793,811],{"trials":831,"activeCount":77},[],{"trials":833,"activeCount":77},[],{"intervention":835,"totalTrials":73,"cells":836},"Intra-amniotic injection of DIGOXIN",{"EARLY_PHASE1":837,"PHASE1":839,"PHASE2":841,"PHASE3":843,"PHASE4":856,"NA":858},{"trials":838,"activeCount":77},[],{"trials":840,"activeCount":77},[],{"trials":842,"activeCount":77},[],{"trials":844,"activeCount":77},[845],{"nctId":846,"briefTitle":847,"status":276,"phases":848,"primaryCompletion":849,"completion":850,"start":513,"enrollment":516,"conditions":851,"interventions":855},"NCT01951079","Intra Amniotic Injection of DIGOXIN for Feticide in Second Trimester Termination of Pregnancy",[68],"2014-11","2014-12",[852,853,854],"Arrhythmia","ECG Changes","Hypotension",[835],{"trials":857,"activeCount":77},[],{"trials":859,"activeCount":77},[],{"intervention":861,"totalTrials":73,"cells":862},"co-biotic",{"EARLY_PHASE1":863,"PHASE1":865,"PHASE2":867,"PHASE3":869,"PHASE4":880,"NA":882},{"trials":864,"activeCount":77},[],{"trials":866,"activeCount":77},[],{"trials":868,"activeCount":77},[],{"trials":870,"activeCount":77},[871],{"nctId":872,"briefTitle":873,"status":630,"phases":874,"primaryCompletion":875,"start":876,"enrollment":77,"conditions":877,"interventions":879},"NCT00846170","Probiotics in Irritable Bowel Syndrome",[68],"2012-03","2010-09",[878],"Irritable Bowel Syndrome",[861],{"trials":881,"activeCount":77},[],{"trials":883,"activeCount":77},[],{"intervention":885,"totalTrials":73,"cells":886},"prostaglandins E2",{"EARLY_PHASE1":887,"PHASE1":889,"PHASE2":891,"PHASE3":893,"PHASE4":901,"NA":903},{"trials":888,"activeCount":77},[],{"trials":890,"activeCount":77},[],{"trials":892,"activeCount":77},[],{"trials":894,"activeCount":77},[895],{"nctId":896,"briefTitle":897,"status":276,"phases":898,"primaryCompletion":633,"completion":633,"start":633,"enrollment":516,"conditions":899,"interventions":900},"NCT00815542","Induction of Labor in Oligohydramnios",[68],[160],[885],{"trials":902,"activeCount":77},[],{"trials":904,"activeCount":77},[],{"intervention":719,"totalTrials":73,"cells":906},{"EARLY_PHASE1":907,"PHASE1":909,"PHASE2":911,"PHASE3":913,"PHASE4":919,"NA":921},{"trials":908,"activeCount":77},[],{"trials":910,"activeCount":77},[],{"trials":912,"activeCount":77},[],{"trials":914,"activeCount":77},[915],{"nctId":713,"briefTitle":714,"status":630,"phases":916,"primaryCompletion":646,"completion":656,"start":648,"enrollment":254,"conditions":917,"interventions":918},[67,68],[717],[702,719],{"trials":920,"activeCount":77},[],{"trials":922,"activeCount":77},[],{"intervention":924,"totalTrials":73,"cells":925},"tranexamic acid",{"EARLY_PHASE1":926,"PHASE1":928,"PHASE2":930,"PHASE3":932,"PHASE4":944,"NA":946},{"trials":927,"activeCount":77},[],{"trials":929,"activeCount":77},[],{"trials":931,"activeCount":77},[],{"trials":933,"activeCount":77},[934],{"nctId":935,"briefTitle":936,"status":276,"phases":937,"primaryCompletion":938,"completion":939,"start":940,"enrollment":516,"conditions":941,"interventions":943},"NCT01496196","The Role of Inhalations of Tranexamic Acid in Patients With Hemoptysis",[68],"2016-01","2016-02","2012-01",[942],"Hemoptisis",[924,924],{"trials":945,"activeCount":77},[],{"trials":947,"activeCount":77},[],{"intervention":949,"totalTrials":73,"cells":950},"THC 5mg\u002Fml and CBS 50mg\u002Fml",{"EARLY_PHASE1":951,"PHASE1":953,"PHASE2":955,"PHASE3":965,"PHASE4":967,"NA":969},{"trials":952,"activeCount":77},[],{"trials":954,"activeCount":77},[],{"trials":956,"activeCount":77},[957],{"nctId":958,"briefTitle":959,"status":224,"phases":960,"primaryCompletion":961,"completion":961,"start":962,"enrollment":254,"conditions":963,"interventions":964},"NCT01826188","Combined THC and CBD Drops for Treatment of Crohn's Disease",[66,67],"2018-06","2013-03",[31],[949],{"trials":966,"activeCount":77},[],{"trials":968,"activeCount":77},[],{"trials":970,"activeCount":77},[],{"intervention":972,"totalTrials":73,"cells":973},"Simvastatin",{"EARLY_PHASE1":974,"PHASE1":976,"PHASE2":978,"PHASE3":988,"PHASE4":990,"NA":992},{"trials":975,"activeCount":77},[],{"trials":977,"activeCount":77},[],{"trials":979,"activeCount":77},[980],{"nctId":981,"briefTitle":982,"status":630,"phases":983,"primaryCompletion":656,"completion":656,"start":984,"enrollment":77,"conditions":985,"interventions":987},"NCT00503763","Efficacy and Safety of Statin on the Course of Progressive Smoldering Multiple Myeloma",[67],"2007-09",[986],"Smoldering Multiple Myeloma",[972],{"trials":989,"activeCount":77},[],{"trials":991,"activeCount":77},[],{"trials":993,"activeCount":77},[],{"intervention":995,"totalTrials":73,"cells":996},"erlotinib",{"EARLY_PHASE1":997,"PHASE1":999,"PHASE2":1001,"PHASE3":1011,"PHASE4":1013,"NA":1015},{"trials":998,"activeCount":77},[],{"trials":1000,"activeCount":77},[],{"trials":1002,"activeCount":77},[1003],{"nctId":1004,"briefTitle":1005,"status":224,"phases":1006,"primaryCompletion":746,"completion":227,"start":646,"enrollment":23,"conditions":1007,"interventions":1009},"NCT00840125","Study of Erlotinib With Docetaxel in Selected Non Small Cell Lung Cancer Patients in First Line Treatment",[67],[1008],"Non-Small Cell Lung Cancer",[995,1010],"docetaxel",{"trials":1012,"activeCount":77},[],{"trials":1014,"activeCount":77},[],{"trials":1016,"activeCount":77},[],{"intervention":1010,"totalTrials":73,"cells":1018},{"EARLY_PHASE1":1019,"PHASE1":1021,"PHASE2":1023,"PHASE3":1029,"PHASE4":1031,"NA":1033},{"trials":1020,"activeCount":77},[],{"trials":1022,"activeCount":77},[],{"trials":1024,"activeCount":77},[1025],{"nctId":1004,"briefTitle":1005,"status":224,"phases":1026,"primaryCompletion":746,"completion":227,"start":646,"enrollment":23,"conditions":1027,"interventions":1028},[67],[1008],[995,1010],{"trials":1030,"activeCount":77},[],{"trials":1032,"activeCount":77},[],{"trials":1034,"activeCount":77},[],{"intervention":1036,"totalTrials":73,"cells":1037},"Bendamustin",{"EARLY_PHASE1":1038,"PHASE1":1040,"PHASE2":1042,"PHASE3":1054,"PHASE4":1056,"NA":1058},{"trials":1039,"activeCount":77},[],{"trials":1041,"activeCount":77},[],{"trials":1043,"activeCount":77},[1044],{"nctId":1045,"briefTitle":1046,"status":276,"phases":1047,"primaryCompletion":91,"completion":91,"start":1048,"enrollment":1049,"conditions":1050,"interventions":1052},"NCT04934930","Adjustment of Chemotherapy Duration in Follicular Lymphoma According to Minimal Residual Disease Status",[67],"2020-01-29",40,[1051],"Follicular Lymphoma",[1036,1053],"Obinutuzumab",{"trials":1055,"activeCount":77},[],{"trials":1057,"activeCount":77},[],{"trials":1059,"activeCount":77},[],{"intervention":1053,"totalTrials":73,"cells":1061},{"EARLY_PHASE1":1062,"PHASE1":1064,"PHASE2":1066,"PHASE3":1072,"PHASE4":1074,"NA":1076},{"trials":1063,"activeCount":77},[],{"trials":1065,"activeCount":77},[],{"trials":1067,"activeCount":77},[1068],{"nctId":1045,"briefTitle":1046,"status":276,"phases":1069,"primaryCompletion":91,"completion":91,"start":1048,"enrollment":1049,"conditions":1070,"interventions":1071},[67],[1051],[1036,1053],{"trials":1073,"activeCount":77},[],{"trials":1075,"activeCount":77},[],{"trials":1077,"activeCount":77},[],{"intervention":1079,"totalTrials":73,"cells":1080},"betamethasone",{"EARLY_PHASE1":1081,"PHASE1":1083,"PHASE2":1085,"PHASE3":1097,"PHASE4":1099,"NA":1101},{"trials":1082,"activeCount":77},[],{"trials":1084,"activeCount":77},[],{"trials":1086,"activeCount":77},[1087],{"nctId":1088,"briefTitle":1089,"status":276,"phases":1090,"primaryCompletion":849,"completion":1091,"start":1092,"enrollment":1093,"conditions":1094,"interventions":1096},"NCT01710384","Effect of Antenatal Corticosteroids in Late Preterm",[67],"2015-11","2012-11",200,[1095],"Late Preterm",[1079],{"trials":1098,"activeCount":77},[],{"trials":1100,"activeCount":77},[],{"trials":1102,"activeCount":77},[],{"intervention":1104,"totalTrials":73,"cells":1105},"cannabidiol",{"EARLY_PHASE1":1106,"PHASE1":1108,"PHASE2":1110,"PHASE3":1122,"PHASE4":1124,"NA":1126},{"trials":1107,"activeCount":77},[],{"trials":1109,"activeCount":77},[],{"trials":1111,"activeCount":77},[1112],{"nctId":1113,"briefTitle":1114,"status":224,"phases":1115,"primaryCompletion":1116,"completion":1116,"start":1117,"enrollment":1118,"conditions":1119,"interventions":1121},"NCT01037322","Cannabidiol for Inflammatory Bowel Disease",[66,67],"2012-09","2010-01",20,[31,1120],"Ulcerative Colitis",[1104],{"trials":1123,"activeCount":77},[],{"trials":1125,"activeCount":77},[],{"trials":1127,"activeCount":77},[],{"intervention":1129,"totalTrials":73,"cells":1130},"smoking of cannabis",{"EARLY_PHASE1":1131,"PHASE1":1133,"PHASE2":1135,"PHASE3":1145,"PHASE4":1147,"NA":1149},{"trials":1132,"activeCount":77},[],{"trials":1134,"activeCount":77},[],{"trials":1136,"activeCount":77},[1137],{"nctId":1138,"briefTitle":1139,"status":276,"phases":1140,"primaryCompletion":633,"completion":1141,"start":1117,"enrollment":1118,"conditions":1142,"interventions":1143},"NCT01040910","Cannabis for Inflammatory Bowel Disease",[66,67],"2012-07",[31,1120],[1129,1144],"smoking cigarettes with placebo",{"trials":1146,"activeCount":77},[],{"trials":1148,"activeCount":77},[],{"trials":1150,"activeCount":77},[],{"intervention":1144,"totalTrials":73,"cells":1152},{"EARLY_PHASE1":1153,"PHASE1":1155,"PHASE2":1157,"PHASE3":1163,"PHASE4":1165,"NA":1167},{"trials":1154,"activeCount":77},[],{"trials":1156,"activeCount":77},[],{"trials":1158,"activeCount":77},[1159],{"nctId":1138,"briefTitle":1139,"status":276,"phases":1160,"primaryCompletion":633,"completion":1141,"start":1117,"enrollment":1118,"conditions":1161,"interventions":1162},[66,67],[31,1120],[1129,1144],{"trials":1164,"activeCount":77},[],{"trials":1166,"activeCount":77},[],{"trials":1168,"activeCount":77},[],{"intervention":1170,"totalTrials":73,"cells":1171},"Fecal microbial l transplantation",{"EARLY_PHASE1":1172,"PHASE1":1174,"PHASE2":1186,"PHASE3":1188,"PHASE4":1190,"NA":1192},{"trials":1173,"activeCount":77},[],{"trials":1175,"activeCount":77},[1176],{"nctId":1177,"briefTitle":1178,"status":249,"phases":1179,"primaryCompletion":1180,"completion":1181,"start":1182,"enrollment":16,"conditions":1183,"interventions":1185},"NCT02391012","Fecal Transplantation for Inflammatory Bowel Disease",[66],"2016-06","2016-07","2015-04",[1184],"Inflammatory Bowel Disease",[1170],{"trials":1187,"activeCount":77},[],{"trials":1189,"activeCount":77},[],{"trials":1191,"activeCount":77},[],{"trials":1193,"activeCount":77},[],{"intervention":1195,"totalTrials":73,"cells":1196},"Injection of Hyaluronic Acid -\" SYNVISC\"",{"EARLY_PHASE1":1197,"PHASE1":1207,"PHASE2":1209,"PHASE3":1211,"PHASE4":1213,"NA":1215},{"trials":1198,"activeCount":77},[1199],{"nctId":1200,"briefTitle":1201,"status":276,"phases":1202,"primaryCompletion":938,"completion":1181,"start":1203,"enrollment":1118,"conditions":1204,"interventions":1206},"NCT02368561","Treatment of Insertional Achilles Tendinopathy by Hyaluronic Acid Injection",[65],"2015-03",[1205],"Insertional Achilles Tendinitis",[1195],{"trials":1208,"activeCount":77},[],{"trials":1210,"activeCount":77},[],{"trials":1212,"activeCount":77},[],{"trials":1214,"activeCount":77},[],{"trials":1216,"activeCount":77},[],{"intervention":1218,"totalTrials":23,"cells":1219},"Vitamin D",{"EARLY_PHASE1":1220,"PHASE1":1222,"PHASE2":1224,"PHASE3":1226,"PHASE4":1228,"NA":1248},{"trials":1221,"activeCount":77},[],{"trials":1223,"activeCount":77},[],{"trials":1225,"activeCount":77},[],{"trials":1227,"activeCount":77},[],{"trials":1229,"activeCount":77},[1230,1239],{"nctId":1231,"briefTitle":1232,"status":276,"phases":1233,"primaryCompletion":746,"completion":540,"start":1234,"enrollment":254,"conditions":1235,"interventions":1238},"NCT01115842","Vitamin D and Inflammatory Cytokine Levels After Acute Myocardial Infraction (MI)",[69],"2010-06",[1236,1237],"Acute Coronary Syndrome","Cytokines",[1218],{"nctId":1240,"briefTitle":1241,"status":276,"phases":1242,"primaryCompletion":391,"completion":391,"start":321,"enrollment":393,"conditions":1243,"interventions":1246},"NCT01417923","The Immune and Clinical Impacts of Vitamin D in Patients With Chronic Musculo-skeletal Pain",[69],[27,1244,1245],"Chronic Pain Syndrome","Inflammatory Response",[1247],"vitamin D",{"trials":1249,"activeCount":77},[1250,1259],{"nctId":1251,"briefTitle":1252,"status":249,"phases":1253,"primaryCompletion":1254,"completion":1254,"start":1255,"enrollment":73,"conditions":1256,"interventions":1258},"NCT02381600","An Evaluation of the Effect of Vitamin D Supplementation on the Cognitive Function of Older Subjects With Low Levels of This Vitamin",[70],"2016-10","2015-10",[1257],"VITAMIN D DEFICIENCY",[1218],{"nctId":1260,"briefTitle":1261,"status":276,"phases":1262,"primaryCompletion":1263,"completion":1264,"start":1265,"enrollment":1093,"conditions":1266,"interventions":1267},"NCT01419821","Vitamin D and Its Affect on Growth Rates and Bone Mineral Density Until Age 5",[70],"2014-09","2016-09","2013-09",[27],[1218],{"intervention":1269,"totalTrials":674,"cells":1270},"methylphenidate",{"EARLY_PHASE1":1271,"PHASE1":1273,"PHASE2":1275,"PHASE3":1277,"PHASE4":1279,"NA":1281},{"trials":1272,"activeCount":77},[],{"trials":1274,"activeCount":77},[],{"trials":1276,"activeCount":77},[],{"trials":1278,"activeCount":77},[],{"trials":1280,"activeCount":77},[],{"trials":1282,"activeCount":77},[1283,1294],{"nctId":1284,"briefTitle":1285,"status":276,"phases":1286,"primaryCompletion":1287,"completion":1288,"start":1289,"enrollment":254,"conditions":1290,"interventions":1293},"NCT02699528","The Effect of Methylphenidate on Primary Enuresis in Children With Attention Deficit Hyperactivity Disorder",[],"2017-04","2017-05","2016-05",[1291,1292],"Attention Deficit Hyperactivity Disorder","Enuresis",[1269],{"nctId":1295,"briefTitle":1296,"status":249,"phases":1297,"primaryCompletion":1298,"completion":1298,"start":1091,"enrollment":1299,"conditions":1300,"interventions":1302},"NCT02180529","The Effects of Methylphenidate on the Cognitive Function of Older People With Mild Cognitive Impairment",[70],"2020-06",16,[1301],"Mild Cognitive Impairment (MCI)",[1303],"Methylphenidate",{"intervention":695,"totalTrials":674,"cells":1305},{"EARLY_PHASE1":1306,"PHASE1":1308,"PHASE2":1310,"PHASE3":1312,"PHASE4":1318,"NA":1320},{"trials":1307,"activeCount":77},[],{"trials":1309,"activeCount":77},[],{"trials":1311,"activeCount":77},[],{"trials":1313,"activeCount":77},[1314],{"nctId":689,"briefTitle":690,"status":276,"phases":1315,"primaryCompletion":391,"completion":692,"start":321,"enrollment":516,"conditions":1316,"interventions":1317},[67,68],[666],[695,696],{"trials":1319,"activeCount":77},[],{"trials":1321,"activeCount":77},[1322],{"nctId":1323,"briefTitle":1324,"status":276,"phases":1325,"primaryCompletion":633,"completion":226,"start":227,"enrollment":441,"conditions":1326,"interventions":1328},"NCT01422460","The Efficacy of Platelets Rich Plasma Injection With PRGF Method in the Treatment for Osteoarthritis of the Subtalar Joint",[70],[1327],"Osteoarthritis of Subtalar Joint",[695],{"intervention":1330,"totalTrials":73,"cells":1331},"Probiotics-Bio-plus",{"EARLY_PHASE1":1332,"PHASE1":1334,"PHASE2":1336,"PHASE3":1338,"PHASE4":1340,"NA":1342},{"trials":1333,"activeCount":77},[],{"trials":1335,"activeCount":77},[],{"trials":1337,"activeCount":77},[],{"trials":1339,"activeCount":77},[],{"trials":1341,"activeCount":77},[],{"trials":1343,"activeCount":77},[1344],{"nctId":1345,"briefTitle":1346,"status":224,"phases":1347,"completion":1348,"start":1349,"enrollment":254,"conditions":1350,"interventions":1352},"NCT00312910","Probiotics for the Prevention of Major Complications of Cirrhosis",[70],"2007-10","2005-04",[1351],"Liver Cirrhosis",[1330],{"intervention":1354,"totalTrials":73,"cells":1355},"PGRF",{"EARLY_PHASE1":1356,"PHASE1":1358,"PHASE2":1360,"PHASE3":1362,"PHASE4":1364,"NA":1366},{"trials":1357,"activeCount":77},[],{"trials":1359,"activeCount":77},[],{"trials":1361,"activeCount":77},[],{"trials":1363,"activeCount":77},[],{"trials":1365,"activeCount":77},[],{"trials":1367,"activeCount":77},[1368],{"nctId":1369,"briefTitle":1370,"status":224,"phases":1371,"primaryCompletion":488,"completion":1372,"start":648,"enrollment":441,"conditions":1373,"interventions":1375},"NCT00725907","Treatment of ATFL Tears With PRP",[70],"2009-01",[1374],"Soft Tissue Healing",[1354],{"intervention":1377,"totalTrials":73,"cells":1378},"Ethanol",{"EARLY_PHASE1":1379,"PHASE1":1381,"PHASE2":1383,"PHASE3":1385,"PHASE4":1387,"NA":1389},{"trials":1380,"activeCount":77},[],{"trials":1382,"activeCount":77},[],{"trials":1384,"activeCount":77},[],{"trials":1386,"activeCount":77},[],{"trials":1388,"activeCount":77},[],{"trials":1390,"activeCount":77},[1391],{"nctId":1392,"briefTitle":1393,"status":276,"phases":1394,"primaryCompletion":1395,"completion":1395,"start":1396,"enrollment":1397,"conditions":1398,"interventions":1401},"NCT02472873","Efficacy of Aspiration and Sclerotherapy During Laparoscopy Using 95% Ethanol for the Treatment of Endometriomas",[70],"2019-06","2015-06",120,[1399,1400],"Endometrioma","Endometriosis",[1377],{"intervention":1403,"totalTrials":73,"cells":1404},"Cream of Macrogol cetostearyl ethers",{"EARLY_PHASE1":1405,"PHASE1":1407,"PHASE2":1409,"PHASE3":1411,"PHASE4":1413,"NA":1415},{"trials":1406,"activeCount":77},[],{"trials":1408,"activeCount":77},[],{"trials":1410,"activeCount":77},[],{"trials":1412,"activeCount":77},[],{"trials":1414,"activeCount":77},[],{"trials":1416,"activeCount":77},[1417],{"nctId":1418,"briefTitle":1419,"status":224,"phases":1420,"primaryCompletion":1421,"completion":1421,"start":251,"enrollment":1422,"conditions":1423,"interventions":1426},"NCT01425619","The Effect of Medical Clowns and Topical Anesthetic Cream on Pain and Anxiety in Children Undergoing Allergy Skin Tests",[70],"2014-04",160,[1424,1425],"Anxiety Disorder","Allergic Skin Reaction",[1403,1427],"Cream of Lidocaine 2.5 %.and Prilocaine 2.5 %",{"intervention":1427,"totalTrials":73,"cells":1429},{"EARLY_PHASE1":1430,"PHASE1":1432,"PHASE2":1434,"PHASE3":1436,"PHASE4":1438,"NA":1440},{"trials":1431,"activeCount":77},[],{"trials":1433,"activeCount":77},[],{"trials":1435,"activeCount":77},[],{"trials":1437,"activeCount":77},[],{"trials":1439,"activeCount":77},[],{"trials":1441,"activeCount":77},[1442],{"nctId":1418,"briefTitle":1419,"status":224,"phases":1443,"primaryCompletion":1421,"completion":1421,"start":251,"enrollment":1422,"conditions":1444,"interventions":1445},[70],[1424,1425],[1403,1427],{"intervention":1447,"totalTrials":73,"cells":1448},"epidural analgesia",{"EARLY_PHASE1":1449,"PHASE1":1451,"PHASE2":1453,"PHASE3":1455,"PHASE4":1457,"NA":1459},{"trials":1450,"activeCount":77},[],{"trials":1452,"activeCount":77},[],{"trials":1454,"activeCount":77},[],{"trials":1456,"activeCount":77},[],{"trials":1458,"activeCount":77},[],{"trials":1460,"activeCount":77},[1461],{"nctId":1462,"briefTitle":1463,"status":224,"phases":1464,"primaryCompletion":1465,"completion":1465,"start":1466,"enrollment":1467,"conditions":1468,"interventions":1470},"NCT04996524","Epidural vs. Systemic Analgesia in the Intensive Care Unit",[70],"2023-04-01","2021-08-01",647,[1469],"Patients With Acute Pain Admitted to the Intensive Care Unit",[1447],{"intervention":1472,"totalTrials":73,"cells":1473},"dehydroepiandrosterone crystalline fine powder",{"EARLY_PHASE1":1474,"PHASE1":1476,"PHASE2":1478,"PHASE3":1480,"PHASE4":1482,"NA":1484},{"trials":1475,"activeCount":77},[],{"trials":1477,"activeCount":77},[],{"trials":1479,"activeCount":77},[],{"trials":1481,"activeCount":77},[],{"trials":1483,"activeCount":77},[],{"trials":1485,"activeCount":77},[1486],{"nctId":1487,"briefTitle":1488,"status":224,"phases":1489,"primaryCompletion":1490,"completion":1490,"start":648,"conditions":1491,"interventions":1493},"NCT01145144","Dehydroepiandrosterone Supplementation for Poor Responder Patients During in Vitro Fertilization Treatment",[70],"2009-07",[1492],"Ovarian Stimulation",[1472],{"intervention":1495,"totalTrials":73,"cells":1496},"Treatment with any inhaled corticosteroid",{"EARLY_PHASE1":1497,"PHASE1":1499,"PHASE2":1501,"PHASE3":1503,"PHASE4":1505,"NA":1507},{"trials":1498,"activeCount":77},[],{"trials":1500,"activeCount":77},[],{"trials":1502,"activeCount":77},[],{"trials":1504,"activeCount":77},[],{"trials":1506,"activeCount":77},[],{"trials":1508,"activeCount":77},[1509],{"nctId":1510,"briefTitle":1511,"status":276,"phases":1512,"primaryCompletion":850,"completion":850,"start":1513,"enrollment":115,"conditions":1514,"interventions":1517},"NCT01839851","Hair Cortisol in Asthma or Allergic Rhinitis Treated With Topical Corticosteroids",[],"2013-05",[1515,1516],"ASTHMA","ALLERGIC RHINITIS",[1495,1518],"Treatment with any intranasal glucocorticoid",{"intervention":1518,"totalTrials":73,"cells":1520},{"EARLY_PHASE1":1521,"PHASE1":1523,"PHASE2":1525,"PHASE3":1527,"PHASE4":1529,"NA":1531},{"trials":1522,"activeCount":77},[],{"trials":1524,"activeCount":77},[],{"trials":1526,"activeCount":77},[],{"trials":1528,"activeCount":77},[],{"trials":1530,"activeCount":77},[],{"trials":1532,"activeCount":77},[1533],{"nctId":1510,"briefTitle":1511,"status":276,"phases":1534,"primaryCompletion":850,"completion":850,"start":1513,"enrollment":115,"conditions":1535,"interventions":1536},[],[1515,1516],[1495,1518],{"intervention":1538,"totalTrials":73,"cells":1539},"Budesonide turbuhaler, Budesonide+Formoterol turbuhaler",{"EARLY_PHASE1":1540,"PHASE1":1542,"PHASE2":1544,"PHASE3":1546,"PHASE4":1548,"NA":1550},{"trials":1541,"activeCount":77},[],{"trials":1543,"activeCount":77},[],{"trials":1545,"activeCount":77},[],{"trials":1547,"activeCount":77},[],{"trials":1549,"activeCount":77},[],{"trials":1551,"activeCount":77},[1552],{"nctId":1553,"briefTitle":1554,"status":276,"phases":1555,"primaryCompletion":251,"completion":1556,"start":876,"enrollment":1557,"conditions":1558,"interventions":1560},"NCT01179152","Study of Preventive Treatment With Symbicort or Budicort Turbohaler in Childhood Asthma Return to School Epidemic",[70],"2012-10",225,[1559],"Asthma Exacerbation",[1538],{"intervention":1562,"totalTrials":73,"cells":1563},"intravenous Thiamine",{"EARLY_PHASE1":1564,"PHASE1":1566,"PHASE2":1568,"PHASE3":1570,"PHASE4":1572,"NA":1574},{"trials":1565,"activeCount":77},[],{"trials":1567,"activeCount":77},[],{"trials":1569,"activeCount":77},[],{"trials":1571,"activeCount":77},[],{"trials":1573,"activeCount":77},[],{"trials":1575,"activeCount":77},[1576],{"nctId":1577,"briefTitle":1578,"status":224,"phases":1579,"primaryCompletion":1580,"completion":1581,"start":1582,"enrollment":808,"conditions":1583,"interventions":1585},"NCT04214106","Thiamine Administration and Prevalence of Delirium in the Intensive Care Unit: A Before-after Study",[],"2020-12-01","2021-01-01","2020-02-19",[1584],"Delirium",[1562],{"intervention":1587,"totalTrials":73,"cells":1588},"Restasis",{"EARLY_PHASE1":1589,"PHASE1":1591,"PHASE2":1593,"PHASE3":1595,"PHASE4":1597,"NA":1599},{"trials":1590,"activeCount":77},[],{"trials":1592,"activeCount":77},[],{"trials":1594,"activeCount":77},[],{"trials":1596,"activeCount":77},[],{"trials":1598,"activeCount":77},[],{"trials":1600,"activeCount":77},[1601],{"nctId":1602,"briefTitle":1603,"status":276,"phases":1604,"primaryCompletion":1605,"completion":1606,"start":1607,"enrollment":1049,"conditions":1608,"interventions":1611},"NCT03403023","Corneal Tear Film Imaging of the Cornea Before and After Restasis Therapy",[70],"2018-05-30","2018-12-30","2018-01-30",[1609,1610],"Dry Eye Syndrome","Tear Film Insufficiency",[1587],{"intervention":1613,"totalTrials":73,"cells":1614},"Oral contraceptive",{"EARLY_PHASE1":1615,"PHASE1":1617,"PHASE2":1619,"PHASE3":1621,"PHASE4":1623,"NA":1625},{"trials":1616,"activeCount":77},[],{"trials":1618,"activeCount":77},[],{"trials":1620,"activeCount":77},[],{"trials":1622,"activeCount":77},[],{"trials":1624,"activeCount":77},[],{"trials":1626,"activeCount":77},[1627],{"nctId":1628,"briefTitle":1629,"status":276,"phases":1630,"primaryCompletion":1631,"completion":589,"start":588,"enrollment":516,"conditions":1632,"interventions":1634},"NCT03230825","Oral Contraceptive Pills Versus Expectant Management for Retained Pregnancy Products",[70],"2018-09",[1633],"Retained Products of Conception Post Abortion",[1613],{"intervention":1636,"totalTrials":73,"cells":1637},"Iron Supplement,",{"EARLY_PHASE1":1638,"PHASE1":1640,"PHASE2":1642,"PHASE3":1644,"PHASE4":1646,"NA":1648},{"trials":1639,"activeCount":77},[],{"trials":1641,"activeCount":77},[],{"trials":1643,"activeCount":77},[],{"trials":1645,"activeCount":77},[],{"trials":1647,"activeCount":77},[],{"trials":1649,"activeCount":77},[1650],{"nctId":1651,"briefTitle":1652,"status":276,"phases":1653,"primaryCompletion":692,"completion":514,"start":1092,"enrollment":1397,"conditions":1654,"interventions":1656},"NCT01676740","Iron and Vitamin Adminstration Prior to Joint Replacement to Prevent Transfusion",[70],[1655],"Excessive Amount of Blood \u002F Fluid Transfusion",[1636],{"intervention":1658,"totalTrials":73,"cells":1659},"Cefazolin",{"EARLY_PHASE1":1660,"PHASE1":1662,"PHASE2":1664,"PHASE3":1666,"PHASE4":1668,"NA":1670},{"trials":1661,"activeCount":77},[],{"trials":1663,"activeCount":77},[],{"trials":1665,"activeCount":77},[],{"trials":1667,"activeCount":77},[],{"trials":1669,"activeCount":77},[],{"trials":1671,"activeCount":77},[1672],{"nctId":1673,"briefTitle":1674,"status":276,"phases":1675,"primaryCompletion":1676,"completion":1677,"start":1678,"enrollment":1679,"conditions":1680,"interventions":1682},"NCT04763486","Prophylactic Antibiotic After Perineal Tear",[70],"2022-03-01","2023-03-01","2021-03-01",2500,[1681],"Puerperal Infection",[1658],{"intervention":1684,"totalTrials":73,"cells":1685},"Letrozole",{"EARLY_PHASE1":1686,"PHASE1":1688,"PHASE2":1690,"PHASE3":1692,"PHASE4":1694,"NA":1696},{"trials":1687,"activeCount":77},[],{"trials":1689,"activeCount":77},[],{"trials":1691,"activeCount":77},[],{"trials":1693,"activeCount":77},[],{"trials":1695,"activeCount":77},[],{"trials":1697,"activeCount":77},[1698],{"nctId":1699,"briefTitle":1700,"status":276,"phases":1701,"primaryCompletion":1702,"completion":1702,"start":961,"enrollment":516,"conditions":1703,"interventions":1705},"NCT03540979","Endometrial Preparation in Frozen Embryo Transfer Cycles",[70],"2019-12",[1704],"Reproductive Behavior",[1684,1706,1707,1708],"Ovidrel","Estrofem","Endometrin 100Mg Vaginal Insert",{"intervention":1706,"totalTrials":73,"cells":1710},{"EARLY_PHASE1":1711,"PHASE1":1713,"PHASE2":1715,"PHASE3":1717,"PHASE4":1719,"NA":1721},{"trials":1712,"activeCount":77},[],{"trials":1714,"activeCount":77},[],{"trials":1716,"activeCount":77},[],{"trials":1718,"activeCount":77},[],{"trials":1720,"activeCount":77},[],{"trials":1722,"activeCount":77},[1723],{"nctId":1699,"briefTitle":1700,"status":276,"phases":1724,"primaryCompletion":1702,"completion":1702,"start":961,"enrollment":516,"conditions":1725,"interventions":1726},[70],[1704],[1684,1706,1707,1708],{"intervention":1707,"totalTrials":73,"cells":1728},{"EARLY_PHASE1":1729,"PHASE1":1731,"PHASE2":1733,"PHASE3":1735,"PHASE4":1737,"NA":1739},{"trials":1730,"activeCount":77},[],{"trials":1732,"activeCount":77},[],{"trials":1734,"activeCount":77},[],{"trials":1736,"activeCount":77},[],{"trials":1738,"activeCount":77},[],{"trials":1740,"activeCount":77},[1741],{"nctId":1699,"briefTitle":1700,"status":276,"phases":1742,"primaryCompletion":1702,"completion":1702,"start":961,"enrollment":516,"conditions":1743,"interventions":1744},[70],[1704],[1684,1706,1707,1708],{"intervention":1708,"totalTrials":73,"cells":1746},{"EARLY_PHASE1":1747,"PHASE1":1749,"PHASE2":1751,"PHASE3":1753,"PHASE4":1755,"NA":1757},{"trials":1748,"activeCount":77},[],{"trials":1750,"activeCount":77},[],{"trials":1752,"activeCount":77},[],{"trials":1754,"activeCount":77},[],{"trials":1756,"activeCount":77},[],{"trials":1758,"activeCount":77},[1759],{"nctId":1699,"briefTitle":1700,"status":276,"phases":1760,"primaryCompletion":1702,"completion":1702,"start":961,"enrollment":516,"conditions":1761,"interventions":1762},[70],[1704],[1684,1706,1707,1708],{"intervention":1764,"totalTrials":73,"cells":1765},"Dorzolamide+Timolol Maleate0.5%",{"EARLY_PHASE1":1766,"PHASE1":1768,"PHASE2":1770,"PHASE3":1772,"PHASE4":1774,"NA":1776},{"trials":1767,"activeCount":77},[],{"trials":1769,"activeCount":77},[],{"trials":1771,"activeCount":77},[],{"trials":1773,"activeCount":77},[],{"trials":1775,"activeCount":77},[],{"trials":1777,"activeCount":77},[1778],{"nctId":1779,"briefTitle":1780,"status":630,"phases":1781,"primaryCompletion":252,"completion":633,"start":488,"enrollment":77,"conditions":1782,"interventions":1785},"NCT00815373","The Effects of Cosopt® Vs Xalacom® on Ocular Hemodynamics and Intraocular Pressure (IOP) in Primary Open-angle Glaucoma (POAG)",[70],[1783,1784],"Open-Angle Glaucoma","Ocular Hypertension",[1764,1786],"Latanoprost+Timolol Maleate0.5%+Lytears",{"intervention":1786,"totalTrials":73,"cells":1788},{"EARLY_PHASE1":1789,"PHASE1":1791,"PHASE2":1793,"PHASE3":1795,"PHASE4":1797,"NA":1799},{"trials":1790,"activeCount":77},[],{"trials":1792,"activeCount":77},[],{"trials":1794,"activeCount":77},[],{"trials":1796,"activeCount":77},[],{"trials":1798,"activeCount":77},[],{"trials":1800,"activeCount":77},[1801],{"nctId":1779,"briefTitle":1780,"status":630,"phases":1802,"primaryCompletion":252,"completion":633,"start":488,"enrollment":77,"conditions":1803,"interventions":1804},[70],[1783,1784],[1764,1786],{"intervention":1806,"totalTrials":73,"cells":1807},"Estriol 0.1% vaginal cream",{"EARLY_PHASE1":1808,"PHASE1":1810,"PHASE2":1812,"PHASE3":1814,"PHASE4":1816,"NA":1818},{"trials":1809,"activeCount":77},[],{"trials":1811,"activeCount":77},[],{"trials":1813,"activeCount":77},[],{"trials":1815,"activeCount":77},[],{"trials":1817,"activeCount":77},[],{"trials":1819,"activeCount":77},[1820],{"nctId":1821,"briefTitle":1822,"status":224,"phases":1823,"primaryCompletion":1265,"completion":1265,"start":647,"enrollment":1824,"conditions":1825,"interventions":1828},"NCT01319968","Postpartum Dyspareunia Resulting From Vaginal Atrophy",[],117,[1826,1827],"Vulvovaginal Atrophy","Dyspareunia Among Puerperal Women",[1806],{"intervention":1830,"totalTrials":73,"cells":1831},"pentoxyphylline",{"EARLY_PHASE1":1832,"PHASE1":1834,"PHASE2":1836,"PHASE3":1838,"PHASE4":1840,"NA":1842},{"trials":1833,"activeCount":77},[],{"trials":1835,"activeCount":77},[],{"trials":1837,"activeCount":77},[],{"trials":1839,"activeCount":77},[],{"trials":1841,"activeCount":77},[],{"trials":1843,"activeCount":77},[1844],{"nctId":1845,"briefTitle":1846,"status":630,"phases":1847,"primaryCompletion":1848,"completion":692,"start":391,"enrollment":77,"conditions":1849,"interventions":1852},"NCT01144091","Renal Effect of Pentoxyphylline in High Risk Patients Undergoing Angiography",[70],"2013-04",[1850,1851],"Contrast Induced Nephropathy","Diabetes Mellitus",[1830,1853],"pentoxiphylline",{"intervention":1853,"totalTrials":73,"cells":1855},{"EARLY_PHASE1":1856,"PHASE1":1858,"PHASE2":1860,"PHASE3":1862,"PHASE4":1864,"NA":1866},{"trials":1857,"activeCount":77},[],{"trials":1859,"activeCount":77},[],{"trials":1861,"activeCount":77},[],{"trials":1863,"activeCount":77},[],{"trials":1865,"activeCount":77},[],{"trials":1867,"activeCount":77},[1868],{"nctId":1845,"briefTitle":1846,"status":630,"phases":1869,"primaryCompletion":1848,"completion":692,"start":391,"enrollment":77,"conditions":1870,"interventions":1871},[70],[1850,1851],[1830,1853],{"intervention":1873,"totalTrials":73,"cells":1874},"fentanyl-based sedation",{"EARLY_PHASE1":1875,"PHASE1":1877,"PHASE2":1879,"PHASE3":1881,"PHASE4":1883,"NA":1885},{"trials":1876,"activeCount":77},[],{"trials":1878,"activeCount":77},[],{"trials":1880,"activeCount":77},[],{"trials":1882,"activeCount":77},[],{"trials":1884,"activeCount":77},[],{"trials":1886,"activeCount":77},[1887],{"nctId":1888,"briefTitle":1889,"status":224,"phases":1890,"primaryCompletion":1891,"completion":1891,"start":1466,"enrollment":254,"conditions":1892,"interventions":1894},"NCT04983615","Opioid vs. Benzodiazepine-based Sedation for Mechanically Ventilated Patients in the Internal Medicine Ward",[70],"2024-08-01",[1893],"Mechanically Ventilated Patients",[1873,1895],"midazolam-based sedation",{"intervention":1895,"totalTrials":73,"cells":1897},{"EARLY_PHASE1":1898,"PHASE1":1900,"PHASE2":1902,"PHASE3":1904,"PHASE4":1906,"NA":1908},{"trials":1899,"activeCount":77},[],{"trials":1901,"activeCount":77},[],{"trials":1903,"activeCount":77},[],{"trials":1905,"activeCount":77},[],{"trials":1907,"activeCount":77},[],{"trials":1909,"activeCount":77},[1910],{"nctId":1888,"briefTitle":1889,"status":224,"phases":1911,"primaryCompletion":1891,"completion":1891,"start":1466,"enrollment":254,"conditions":1912,"interventions":1913},[70],[1893],[1873,1895],{"intervention":1915,"totalTrials":73,"cells":1916},"application of the allergenic food",{"EARLY_PHASE1":1917,"PHASE1":1919,"PHASE2":1921,"PHASE3":1923,"PHASE4":1925,"NA":1927},{"trials":1918,"activeCount":77},[],{"trials":1920,"activeCount":77},[],{"trials":1922,"activeCount":77},[],{"trials":1924,"activeCount":77},[],{"trials":1926,"activeCount":77},[],{"trials":1928,"activeCount":77},[1929],{"nctId":1930,"briefTitle":1931,"status":276,"phases":1932,"primaryCompletion":1933,"completion":1934,"start":1935,"enrollment":1936,"conditions":1937,"interventions":1939},"NCT05080127","The Feasibility of Systemic Reaction After Contact Exposure to the Allergenic Food in Children With Known Food Allergy",[70],"2023-07","2023-12","2021-07-28",600,[25,1938],"Quality of Life",[1915],{"intervention":1941,"totalTrials":73,"cells":1942},"Loteprednol Etabonate",{"EARLY_PHASE1":1943,"PHASE1":1945,"PHASE2":1947,"PHASE3":1949,"PHASE4":1951,"NA":1953},{"trials":1944,"activeCount":77},[],{"trials":1946,"activeCount":77},[],{"trials":1948,"activeCount":77},[],{"trials":1950,"activeCount":77},[],{"trials":1952,"activeCount":77},[],{"trials":1954,"activeCount":77},[1955],{"nctId":1956,"briefTitle":1957,"status":276,"phases":1958,"primaryCompletion":366,"completion":366,"start":1263,"enrollment":441,"conditions":1959,"interventions":1961},"NCT02218827","Topical Steroid Treatment For Dry Eye",[70],[1960],"Dry Eye",[1941],{"intervention":1963,"totalTrials":73,"cells":1964},"Administration of methadone instead of fentanyl patch",{"EARLY_PHASE1":1965,"PHASE1":1967,"PHASE2":1969,"PHASE3":1971,"PHASE4":1973,"NA":1975},{"trials":1966,"activeCount":77},[],{"trials":1968,"activeCount":77},[],{"trials":1970,"activeCount":77},[],{"trials":1972,"activeCount":77},[],{"trials":1974,"activeCount":77},[],{"trials":1976,"activeCount":77},[1977],{"nctId":1978,"briefTitle":1979,"status":224,"phases":1980,"primaryCompletion":1981,"completion":1981,"start":1982,"enrollment":516,"conditions":1983,"interventions":1985},"NCT05697783","Methadone vs. Transdermal Fentanyl for Opioid Withdrawal Syndrome",[],"2024-02-01","2023-12-01",[1984],"Delirium in the Intensive Care Unit",[1963],{"intervention":1987,"totalTrials":73,"cells":1988},"povidone iodine",{"EARLY_PHASE1":1989,"PHASE1":1991,"PHASE2":1993,"PHASE3":1995,"PHASE4":1997,"NA":1999},{"trials":1990,"activeCount":77},[],{"trials":1992,"activeCount":77},[],{"trials":1994,"activeCount":77},[],{"trials":1996,"activeCount":77},[],{"trials":1998,"activeCount":77},[],{"trials":2000,"activeCount":77},[2001],{"nctId":2002,"briefTitle":2003,"status":276,"phases":2004,"primaryCompletion":1141,"completion":2005,"start":2006,"enrollment":2007,"conditions":2008,"interventions":2010},"NCT01350713","The Counter-irritating Efficacy of Topical Povidone-iodine in Thermal Burns",[70],"2013-07","2011-07",280,[2009],"Skin Burns",[1987],{"intervention":2012,"totalTrials":73,"cells":2013},"Moxifloxacin ophthalmic solution 0.5% ; Gatifloxacin ophthalmic solution 0.3%",{"EARLY_PHASE1":2014,"PHASE1":2016,"PHASE2":2018,"PHASE3":2020,"PHASE4":2022,"NA":2024},{"trials":2015,"activeCount":77},[],{"trials":2017,"activeCount":77},[],{"trials":2019,"activeCount":77},[],{"trials":2021,"activeCount":77},[],{"trials":2023,"activeCount":77},[],{"trials":2025,"activeCount":77},[2026],{"nctId":2027,"briefTitle":2028,"status":276,"phases":2029,"primaryCompletion":1234,"completion":1234,"start":2030,"enrollment":1049,"conditions":2031,"interventions":2033},"NCT00892918","Effect of Moxifloxacin Versus Gatifloxacin on Corneal Epithelium Following Pterygium Excision",[70],"2009-06",[2032],"Primary Pterygium",[2012],{"intervention":2035,"totalTrials":73,"cells":2036},"use of fentanyl patch that was halved",{"EARLY_PHASE1":2037,"PHASE1":2039,"PHASE2":2041,"PHASE3":2043,"PHASE4":2045,"NA":2047},{"trials":2038,"activeCount":77},[],{"trials":2040,"activeCount":77},[],{"trials":2042,"activeCount":77},[],{"trials":2044,"activeCount":77},[],{"trials":2046,"activeCount":77},[],{"trials":2048,"activeCount":77},[2049],{"nctId":2050,"briefTitle":2051,"status":276,"phases":2052,"primaryCompletion":590,"completion":365,"start":875,"enrollment":2053,"conditions":2054,"interventions":2056},"NCT01403363","Use of Fentanyl Patch in Partial Doses Than the Original",[70],95,[2055],"Chronic Pain",[2035],{"intervention":2058,"totalTrials":73,"cells":2059},"Combigan",{"EARLY_PHASE1":2060,"PHASE1":2062,"PHASE2":2064,"PHASE3":2066,"PHASE4":2068,"NA":2070},{"trials":2061,"activeCount":77},[],{"trials":2063,"activeCount":77},[],{"trials":2065,"activeCount":77},[],{"trials":2067,"activeCount":77},[],{"trials":2069,"activeCount":77},[],{"trials":2071,"activeCount":77},[2072],{"nctId":2073,"briefTitle":2074,"status":276,"phases":2075,"primaryCompletion":2076,"completion":2077,"start":2078,"enrollment":2079,"conditions":2080,"interventions":2082},"NCT02718547","The Relationship Between Intraocular Pressure and Macular Edema in Patients With Diabetic Macular Edema",[70],"2018-03-30","2018-07","2017-03-26",25,[2081],"Complications of Diabetes Mellitus",[2058],{"intervention":2084,"totalTrials":73,"cells":2085},"estriol cream",{"EARLY_PHASE1":2086,"PHASE1":2088,"PHASE2":2090,"PHASE3":2092,"PHASE4":2094,"NA":2096},{"trials":2087,"activeCount":77},[],{"trials":2089,"activeCount":77},[],{"trials":2091,"activeCount":77},[],{"trials":2093,"activeCount":77},[],{"trials":2095,"activeCount":77},[],{"trials":2097,"activeCount":77},[2098],{"nctId":2099,"briefTitle":2100,"status":224,"phases":2101,"primaryCompletion":2102,"completion":2103,"start":2104,"enrollment":2105,"conditions":2106,"interventions":2108},"NCT02892214","The Reciprocal Relations Between Psychosocial Characteristics and the Progression of Vestibulodynia",[],"2020-12","2021-12","2016-11-30",113,[2107],"Localized Provoked Vulvodynia",[2084],{"intervention":2110,"totalTrials":73,"cells":2111},"testosterone undecanoate",{"EARLY_PHASE1":2112,"PHASE1":2114,"PHASE2":2116,"PHASE3":2118,"PHASE4":2120,"NA":2122},{"trials":2113,"activeCount":77},[],{"trials":2115,"activeCount":77},[],{"trials":2117,"activeCount":77},[],{"trials":2119,"activeCount":77},[],{"trials":2121,"activeCount":77},[],{"trials":2123,"activeCount":77},[2124],{"nctId":2125,"briefTitle":2126,"status":276,"phases":2127,"primaryCompletion":2128,"completion":2128,"start":2129,"enrollment":393,"conditions":2130,"interventions":2132},"NCT01758029","Testosterone Undecanoate and Quality of Life of Men and Spouses",[],"2014-07","2013-01",[2131],"Hypogonadism",[2110],{"intervention":2134,"totalTrials":73,"cells":2135},"Decapeptyl",{"EARLY_PHASE1":2136,"PHASE1":2138,"PHASE2":2140,"PHASE3":2142,"PHASE4":2144,"NA":2146},{"trials":2137,"activeCount":77},[],{"trials":2139,"activeCount":77},[],{"trials":2141,"activeCount":77},[],{"trials":2143,"activeCount":77},[],{"trials":2145,"activeCount":77},[],{"trials":2147,"activeCount":77},[2148],{"nctId":2149,"briefTitle":2150,"status":276,"phases":2151,"primaryCompletion":2152,"completion":2153,"start":2154,"enrollment":254,"conditions":2155,"interventions":2156},"NCT02827656","Comapring Luteal Phase Support in IVF Patients Who Are at High Risk for Developing OHSS",[70],"2017-08","2017-12","2016-08",[15],[2134,2157],"hCG luteal support",{"intervention":2157,"totalTrials":73,"cells":2159},{"EARLY_PHASE1":2160,"PHASE1":2162,"PHASE2":2164,"PHASE3":2166,"PHASE4":2168,"NA":2170},{"trials":2161,"activeCount":77},[],{"trials":2163,"activeCount":77},[],{"trials":2165,"activeCount":77},[],{"trials":2167,"activeCount":77},[],{"trials":2169,"activeCount":77},[],{"trials":2171,"activeCount":77},[2172],{"nctId":2149,"briefTitle":2150,"status":276,"phases":2173,"primaryCompletion":2152,"completion":2153,"start":2154,"enrollment":254,"conditions":2174,"interventions":2175},[70],[15],[2134,2157],{"intervention":2177,"totalTrials":73,"cells":2178},"Beta-lactam oral challenge",{"EARLY_PHASE1":2179,"PHASE1":2181,"PHASE2":2183,"PHASE3":2185,"PHASE4":2187,"NA":2189},{"trials":2180,"activeCount":77},[],{"trials":2182,"activeCount":77},[],{"trials":2184,"activeCount":77},[],{"trials":2186,"activeCount":77},[],{"trials":2188,"activeCount":77},[],{"trials":2190,"activeCount":77},[2191],{"nctId":2192,"briefTitle":2193,"status":224,"phases":2194,"primaryCompletion":1396,"completion":1396,"start":875,"enrollment":1093,"conditions":2195,"interventions":2197},"NCT01520181","Extended Open Challenge in Patients With a History of Drug Eruption Following Beta-lactam Treatment",[70],[2196],"Beta-lactam Allergy",[2177],{"intervention":2199,"totalTrials":73,"cells":2200},"Topical hormonal cream",{"EARLY_PHASE1":2201,"PHASE1":2203,"PHASE2":2205,"PHASE3":2207,"PHASE4":2209,"NA":2211},{"trials":2202,"activeCount":77},[],{"trials":2204,"activeCount":77},[],{"trials":2206,"activeCount":77},[],{"trials":2208,"activeCount":77},[],{"trials":2210,"activeCount":77},[],{"trials":2212,"activeCount":77},[2213],{"nctId":2214,"briefTitle":2215,"status":224,"phases":2216,"primaryCompletion":2217,"completion":2218,"start":2104,"enrollment":2105,"conditions":2219,"interventions":2221},"NCT02712814","Subtypes of Provoked Vestibulodynia",[],"2019-06-30","2021-08",[2220],"Provoked Localized Vulvodynia",[2199],{"intervention":2223,"totalTrials":73,"cells":2224},"vitamin B12 treatment",{"EARLY_PHASE1":2225,"PHASE1":2227,"PHASE2":2229,"PHASE3":2231,"PHASE4":2233,"NA":2235},{"trials":2226,"activeCount":77},[],{"trials":2228,"activeCount":77},[],{"trials":2230,"activeCount":77},[],{"trials":2232,"activeCount":77},[],{"trials":2234,"activeCount":77},[],{"trials":2236,"activeCount":77},[2237],{"nctId":2238,"briefTitle":2239,"status":249,"phases":2240,"primaryCompletion":2241,"completion":2241,"start":633,"enrollment":2242,"conditions":2243,"interventions":2245},"NCT01127724","Influence of Different Doses of the Vitamin B12 on Recurrent Aphthous Stomatitis",[70],"2014-10",8,[2244],"Recurrent Aphthous Stomatitis",[2223]]